Moreover, the DOCK2 genetic variant caused decreased DOCK2 mRNA transcript levels and might be a prognostic biomarker of non-small-cell lung cancer survival (Du et al., 2021). The gene discussed is DOCK2; the disease is non-small cell lung carcinoma.